Swift Biosciences Raises $12.2M

Jun 29, 2017

|

NEW YORK (GenomeWeb) – Swift Biosciences announced today that it has raised $12.2 million through a Series D round of financing.

The round was led by venture capital firm Arboretum Ventures and included existing Swift investors. The company, which develops next-generation sequencing sample prep technologies, said that it intends to use the funding to expand its global commercial channels, as well as enhance its manufacturing and operation capabilities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Synthetic Genomics Sued for Gender Discrimination

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Football Team's DNA Day Postponed

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

To Interfere

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

This Week in Cell

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Featured White Papers

Next Generation Mapping Identifies Large Structural Variants in Plant and Animal Genomes

Simple and Automatic Normalization of Sample Concentrations

Hybrid Scaffolding Improves Genome Assembly Accuracy and Contiguity

Sep

26

Featured Webinar

GenomeWeb/ABRF 2017 Webinar Series: CITE-seq: Large-Scale Measurement of Epitopes and Transcriptomes in Single Cells

This webinar will describe a protocol and proof-of-principle experiments for Cellular Indexing of Transcriptome and Epitopes by Sequencing (CITE-seq).

Sep

27

Featured Webinar

Large-scale, Prospective Tumor and Normal Sequence to Accelerate Biomarker Discovery and Guide Clinical Care

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep

28

Featured Webinar

Clinical Utility of Comprehensive and Fast Genomic Interpretation

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.

Oct

12

Featured Webinar

Precision Oncology Roundtable: Ask the Experts about NGS-based Tumor Profiling

This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers.

Main menu